Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biologic; Inadequate”

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT06020144
What this trial is testing

Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs

Who this might be right for
Rheumatoid Arthritis
Hangzhou Highlightll Pharmaceutical Co., Ltd 459
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Large-scale testing (Phase 3)Looking for participantsNCT07286058
What this trial is testing

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Takeda 1,182
Large-scale testing (Phase 3)Study completedNCT00810277
What this trial is testing

Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 14
Large-scale testing (Phase 3)Study completedNCT02046603
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 162
Large-scale testing (Phase 3)Study completedNCT02873936
What this trial is testing

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 449
Large-scale testing (Phase 3)Study completedNCT02001987
What this trial is testing

Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 139
Large-scale testing (Phase 3)Study completedNCT00124982
What this trial is testing

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,286
Large-scale testing (Phase 3)Ended earlyNCT04115839
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy

Who this might be right for
Psoriatic Arthritis
Gilead Sciences 106
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Post-approval studies (Phase 4)Study completedNCT01481142
What this trial is testing

Adacolumn in Refractory UC Patients Trial

Who this might be right for
Ulcerative Colitis, Active Moderate
Otsuka Pharmaceutical Europe Ltd 100
Testing effectiveness (Phase 2)Study completedNCT00221000
What this trial is testing

Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mallinckrodt 86
Large-scale testing (Phase 3)Study completedNCT03671148
What this trial is testing

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)

Who this might be right for
Psoriatic Arthritis (PsA)
AbbVie 444
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Large-scale testing (Phase 3)Study completedNCT01709578
What this trial is testing

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

Who this might be right for
Rheumatoid Arthritis
Sanofi 546
Not applicableStudy completedNCT01617005
What this trial is testing

Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT01059773
What this trial is testing

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

Who this might be right for
Psoriasis
Janssen-Cilag International NV 490
Post-approval studies (Phase 4)Study completedNCT01195272
What this trial is testing

The Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 21

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation